www.amex.com


American Stock Exchange News Release

Equity Release

Media Contact: Catherine Chantharaj
American Stock Exchange
212-306-1689 / catherine.chantharaj@amex.com

 

AMERICAN STOCK EXCHANGE LISTS THE COMMON STOCK OF CARDIUM THERAPEUTICS, INC.

New York, August 1, 2007 — The American Stock Exchange® (Amex®) today listed the common stock of Cardium Therapeutics, Inc. under the ticker symbol CXM.

Cardium Therapeutics, Inc. is a medical technology company primarily focused on the development, manufacture and sale of innovative products for cardiovascular and related indications.
 
“We proudly welcome Cardium Therapeutics, Inc. to the American Stock Exchange,” said John McGonegal, Senior Vice President of Amex Equities Group. “Many new medical technology companies have chosen to list at the Amex, and we are pleased that Cardium Therapeutics is the latest company to recognize our expanding presence in this important sector.”

The specialist in Cardium Therapeutics, Inc. will be HBH Specialists LLC. For further information on CXM and other Amex-listed companies, please visit www.amex.com.

About American Stock Exchange
The American Stock Exchange® (Amex®) offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRSSM. In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 336 ETFs to date. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks.